Suppr
超能文献

QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.

作者信息

Chinello Pierangelo, Petrosillo Nicola, Pittalis Silvia, Biava Gianluigi, Ippolito Giuseppe, Nicastri Emanuele

机构信息

Lazzaro Spallanzani National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy.

出版信息

PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006034. doi: 10.1371/journal.pntd.0006034. eCollection 2017 Dec.

DOI:10.1371/journal.pntd.0006034

PMID:29283993

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5746205/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f189/5746205/2f0e0770cf25/pntd.0006034.g001.jpg

相似文献

QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.

PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006034. doi: 10.1371/journal.pntd.0006034. eCollection 2017 Dec.

Favipiravir: a new medication for the Ebola virus disease pandemic.

Disaster Med Public Health Prep. 2015 Feb;9(1):79-81. doi: 10.1017/dmp.2014.151. Epub 2014 Dec 29.

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.

Antiviral Res. 2014 May;105:17-21. doi: 10.1016/j.antiviral.2014.02.014. Epub 2014 Feb 26.

Intracellular conversion and in vivo dose response of favipiravir (T-705) in rodents infected with Ebola virus.

Antiviral Res. 2018 Mar;151:50-54. doi: 10.1016/j.antiviral.2017.12.020. Epub 2017 Dec 28.

Ribavirin does not potentiate favipiravir antiviral activity against Ebola virus in non-human primates.

Antiviral Res. 2020 May;177:104758. doi: 10.1016/j.antiviral.2020.104758. Epub 2020 Mar 2.

Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.

Nat Commun. 2018 Oct 1;9(1):4013. doi: 10.1038/s41467-018-06215-z.

Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study.

J Infect Dis. 2019 Jun 19;220(2):195-202. doi: 10.1093/infdis/jiz078.

Recent progress on the treatment of Ebola virus disease with Favipiravir and other related strategies.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2364-2368. doi: 10.1016/j.bmcl.2017.04.028. Epub 2017 Apr 12.

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar.

Favipiravir for children with Ebola.

Lancet. 2015 Feb 14;385(9968):603-604. doi: 10.1016/S0140-6736(15)60232-X.

引用本文的文献

Favipiravir-induced bradycardia: A case report.

Clin Case Rep. 2024 Jun 27;12(7):e9052. doi: 10.1002/ccr3.9052. eCollection 2024 Jul.

Prolonged Exposure to Remdesivir Inhibits the Human Ether-A-Go-Go-Related Gene Potassium Current.

J Cardiovasc Pharmacol. 2023 Sep 1;82(3):212-220. doi: 10.1097/FJC.0000000000001449.

Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections.

Pharm Res. 2023 May;40(5):1015-1036. doi: 10.1007/s11095-023-03520-1. Epub 2023 Apr 25.

Transient left bundle branch block associated with favipiravir treatment for coronavirus infection.

J Interv Card Electrophysiol. 2023 Sep;66(6):1321-1322. doi: 10.1007/s10840-023-01548-2. Epub 2023 Apr 26.

Cardiovascular implications of the COVID-19: Management of complications and drug safety concerns.

J Res Med Sci. 2022 Dec 23;27:92. doi: 10.4103/jrms.jrms_895_21. eCollection 2022.

Pulmonary Delivery of Favipiravir in Rats Reaches High Local Concentrations without Causing Oxidative Lung Injury or Systemic Side Effects.

Pharmaceutics. 2022 Nov 4;14(11):2375. doi: 10.3390/pharmaceutics14112375.

The association between QT interval changes and the treatment protocols of COVID-19 patients.

North Clin Istanb. 2022 Jul 7;9(3):199-206. doi: 10.14744/nci.2022.86836. eCollection 2022.

The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort.

Front Med (Lausanne). 2022 Aug 31;9:894126. doi: 10.3389/fmed.2022.894126. eCollection 2022.

Favipiravir for the treatment of COVID-19 in elderly patients-what do we know after 2 years of COVID-19?

Geroscience. 2022 Jun;44(3):1263-1268. doi: 10.1007/s11357-022-00582-8. Epub 2022 May 11.

High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea.

IDCases. 2022 Jan 21;27:e01412. doi: 10.1016/j.idcr.2022.e01412. eCollection 2022.

本文引用的文献

Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.

Clin Infect Dis. 2016 Nov 15;63(10):1288-1294. doi: 10.1093/cid/ciw571. Epub 2016 Aug 23.

Cardiac MRI Findings Suggest Myocarditis in Severe Ebola Virus Disease.

JACC Cardiovasc Imaging. 2017 Jun;10(6):711-713. doi: 10.1016/j.jcmg.2016.06.004. Epub 2016 Aug 17.

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

PLoS Med. 2016 Mar 1;13(3):e1001967. doi: 10.1371/journal.pmed.1001967. eCollection 2016 Mar.

Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults.

Int J Clin Pharmacol Ther. 2015 Oct;53(10):866-74. doi: 10.5414/CP202388.

Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States.

Crit Care Med. 2015 Oct;43(10):2066-75. doi: 10.1097/CCM.0000000000001197.

Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus-Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death.

J Infect Dis. 2016 Jan 1;213(1):57-60. doi: 10.1093/infdis/jiv357. Epub 2015 Jul 7.

Favipiravir--a prophylactic treatment for Ebola contacts?

Lancet. 2015 Jun 13;385(9985):2350. doi: 10.1016/S0140-6736(15)61095-9.

Dose regimen of favipiravir for Ebola virus disease.

Lancet Infect Dis. 2015 Feb;15(2):150-1. doi: 10.1016/S1473-3099(14)71047-3. Epub 2014 Nov 28.

Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.

J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456.

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.

Antiviral Res. 2014 May;105:17-21. doi: 10.1016/j.antiviral.2014.02.014. Epub 2014 Feb 26.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译